MED15 | Mediator complex subunit 15 | | | | | | Expressed in all |
PI4KA | Phosphatidylinositol 4-kinase, catalytic, alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SERPIND1 | Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SNAP29 | Synaptosomal-associated protein, 29kDa | Disease related genes
| | | | | Expressed in all |
CRKL | V-crk avian sarcoma virus CT10 oncogene homolog-like | Plasma proteins
| | | | | Expressed in all |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins
| | | | | Group enriched |
THAP7 | THAP domain containing 7 | Transcription factors
| | | | | Expressed in all |
P2RX6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC7A4 | Solute carrier family 7, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC002472.13 | Leucine-rich repeat-containing protein LOC400891 | | | | | | Tissue enhanced |
POM121L7 | POM121 transmembrane nucleoporin-like 7 | | | | | | Tissue enriched |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
RIMBP3B | RIMS binding protein 3B | | | | | | Tissue enriched |
HIC2 | Hypermethylated in cancer 2 | Transcription factors
| | | | | Mixed |
RIMBP3C | RIMS binding protein 3C | | | | | | Tissue enriched |
UBE2L3 | Ubiquitin-conjugating enzyme E2L 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
YDJC | YdjC homolog (bacterial) | | | | | | Mixed |
CCDC116 | Coiled-coil domain containing 116 | | | | | | Tissue enriched |
SDF2L1 | Stromal cell-derived factor 2-like 1 | Predicted secreted proteins
| | | | | Expressed in all |
PPIL2 | Peptidylprolyl isomerase (cyclophilin)-like 2 | Enzymes
| | | | | Expressed in all |
YPEL1 | Yippee-like 1 (Drosophila) | | | | | | Tissue enhanced |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PPM1F | Protein phosphatase, Mg2+/Mn2+ dependent, 1F | Enzymes Plasma proteins
| | | | | Expressed in all |
TOP3B | Topoisomerase (DNA) III beta | Enzymes Plasma proteins
| | | | | Expressed in all |
VPREB1 | Pre-B lymphocyte 1 | CD markers Predicted secreted proteins
| | | | | Tissue enriched |
ZNF280B | Zinc finger protein 280B | Transcription factors
| | | | | Tissue enriched |
ZNF280A | Zinc finger protein 280A | Transcription factors
| | | | | Not detected |
PRAME | Preferentially expressed antigen in melanoma | Plasma proteins
| | | | | Tissue enriched |
GGTLC2 | Gamma-glutamyltransferase light chain 2 | | | | | | Tissue enhanced |
IGLL5 | Immunoglobulin lambda-like polypeptide 5 | | | | | | Tissue enhanced |
RTDR1 | Rhabdoid tumor deletion region gene 1 | | | | | | Tissue enhanced |
GNAZ | Guanine nucleotide binding protein (G protein), alpha z polypeptide | | | | | | Tissue enhanced |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
C22orf43 | Chromosome 22 open reading frame 43 | | | | | | Tissue enriched |
RGL4 | Ral guanine nucleotide dissociation stimulator-like 4 | Predicted secreted proteins
| | | | | Tissue enriched |
ZNF70 | Zinc finger protein 70 | Transcription factors
| | | | | Mixed |
VPREB3 | Pre-B lymphocyte 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
C22orf15 | Chromosome 22 open reading frame 15 | Predicted secreted proteins
| | | | | Tissue enriched |
CHCHD10 | Coiled-coil-helix-coiled-coil-helix domain containing 10 | Mitochondrial proteins
| | | | | Expressed in all |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
DERL3 | Derlin 3 | Plasma proteins Predicted membrane proteins
| | | | | Mixed |
SLC2A11 | Solute carrier family 2 (facilitated glucose transporter), member 11 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
AP000350.10 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
AP000350.4 | Uncharacterized protein | | | | | | Mixed |
GSTT2B | Glutathione S-transferase theta 2B (gene/pseudogene) | Enzymes
| | | | | Tissue enhanced |
DDT | D-dopachrome tautomerase | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GSTT2 | Glutathione S-transferase theta 2 | Enzymes
| | | | | Tissue enhanced |
GSTT1 | Glutathione S-transferase theta 1 | Cancer-related genes Enzymes
| | | | | Expressed in all |